Insights

Healthcare Focused AI AKASA specializes in generative AI solutions specifically designed for the healthcare revenue cycle, making it highly relevant for hospitals and health systems seeking advanced automation to improve operational efficiency and financial performance.

Strong Market Position With over 200 million dollars raised from prominent investors like Andreessen Horowitz and Costanoa Ventures, AKASA demonstrates solid financial backing and a strong growth trajectory, indicating ample opportunity to scale its AI offerings within the healthcare sector.

Recent Product Launches The launch of innovative tools such as AKASA CDI Optimizer, Medical Coding, and Authorization Advisor shows ongoing product development that can address multiple pain points in revenue cycle management, presenting opportunities for cross-selling or expanding existing client relationships.

Expanding Customer Base Participation in industry events like the HFMA Western Region Symposium and collaborations with renowned health care institutions signal an active effort to grow visibility and acquire new hospital and health system clients that are seeking AI-driven solutions.

Industry Trends Alignment The company's focus on leveraging generative AI to streamline revenue cycle processes aligns well with current industry trends towards digital transformation and automation in healthcare, making AKASA’s solutions highly relevant for prospective clients aiming to modernize their operations.

AKASA Tech Stack

AKASA uses 8 technology products and services including OpenSearch, OAuth, Asana, and more. Explore AKASA's tech stack below.

  • OpenSearch
    Analytics
  • OAuth
    Identity And Access Management
  • Asana
    Issue Trackers
  • SEMrush
    Marketing Automation
  • Go
    Programming Languages
  • Node.js
    Programming Languages
  • Ahrefs
    Search Marketing
  • Facebook
    Widgets

Media & News

AKASA's Email Address Formats

AKASA uses at least 1 format(s):
AKASA Email FormatsExamplePercentage
First.Last@akasa.comJohn.Doe@akasa.com
93%
First@akasa.comJohn@akasa.com
4%
FLast@akasa.comJDoe@akasa.com
2%
Last@akasa.comDoe@akasa.com
1%

Frequently Asked Questions

What is AKASA's stock symbol?

Minus sign iconPlus sign icon
AKASA is a publicly traded company; the company's stock symbol is 6022.T.

What is AKASA's official website and social media links?

Minus sign iconPlus sign icon
AKASA's official website is akasa.com and has social profiles on LinkedInCrunchbase.

What is AKASA's NAICS code?

Minus sign iconPlus sign icon
AKASA's NAICS code is 5112 - Software Publishers.

How many employees does AKASA have currently?

Minus sign iconPlus sign icon
As of January 2026, AKASA has approximately 210 employees across 5 continents, including North AmericaAsiaAfrica. Key team members include Chief Product Officer: C. C.Head Of Commercial Growth: R. T.Head Of Deployment: M. S.. Explore AKASA's employee directory with LeadIQ.

What industry does AKASA belong to?

Minus sign iconPlus sign icon
AKASA operates in the Software Development industry.

What technology does AKASA use?

Minus sign iconPlus sign icon
AKASA's tech stack includes OpenSearchOAuthAsanaSEMrushGoNode.jsAhrefsFacebook.

What is AKASA's email format?

Minus sign iconPlus sign icon
AKASA's email format typically follows the pattern of First.Last@akasa.com. Find more AKASA email formats with LeadIQ.

When was AKASA founded?

Minus sign iconPlus sign icon
AKASA was founded in 2019.

AKASA

Software DevelopmentCalifornia, United States201-500 Employees

Healthcare revenue cycle teams are strained. Volumes are rising, margins are constricting, and hiring and retaining enough staff is impossible. That’s why you need technology. It’s the only way things are going to get better. 

AKASA is the preeminent provider of generative AI solutions for the healthcare revenue cycle

Our offerings are built on the AKASA Platform, which integrates the company’s proprietary generative AI technology and deep revenue cycle expertise to deliver exceptional impact for hospitals, health systems, and the patients they serve. 

AKASA is the only AI company whose technology is trained on a health system’s own clinical and financial data, enabling AI to better understand the specific nuances of a health system. 

With investors including Andreessen Horowitz, BOND, Costanoa Ventures, and others, we’ve raised more than $200M to help eliminate the financial complexity of healthcare.

We’re rebuilding the healthcare revenue cycle with AI. Let’s chat.

Section iconCompany Overview

Website
akasa.com
Stock Symbol
6022.T
NAICS Code
5112 - Software Publishers
Founded
2019
Employees
201-500

Section iconFunding & Financials

  • $100M$250M

    AKASA's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    AKASA's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.